Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study — Stella

Home/Mild Alzheimer's Disease/

View on ClinicalTrials.gov

Recruiting

Back to Mild Alzheimer's Disease trials

Trial locations(1 site)

United States

Centers for Medicare and Medicaid Services, Baltimore, Maryland

Key details

Sponsor

Centers for Medicare and Medicaid Services/ Coverage and Analysis Group

Enrollment target

~8,680 participants

Started

July 2023

Primary completion

June 2028

Last updated September 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.